UPDATE: Doctor, Nurse Treated with ZMapp Show Marked Improvement - Bloomberg Citing WHO

(Updated - August 21, 2014 12:34 PM EDT)

One doctor and one nurse treated with ZMAPP, an experimental treatment for Ebola, showed marked improvement, according to Bloomberg, citing WHO. A third doctor has improved but remains in serious condition. Supplies of ZMapp have been exhausted, the report said.

Zmapp is being developed by Mapp Biopharmaceutical. Other companies with experimental drugs to treat Ebola include Tekmira Pharmaceuticals (NASDAQ: TKMR), BioCryst Pharma (NASDAQ: BCRX), NewLink Genetics (NASDAQ: NLNK), and Sarepta Therapeutics (NASDAQ: SRPT).

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• NBA in talks with Amazon, Youtube on new streaming package - WSJ
• T-Mobile to invest $950 million in venture with EQT to buy fiber optic network provider Lumos
• Amazon Prime Video to exclusively stream two NHL seasons in Canada